Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension
about
Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension
description
scientific article published on 20 May 2020
@en
name
Administration of apo A-I (Mil ...... F associated with hypertension
@en
type
label
Administration of apo A-I (Mil ...... F associated with hypertension
@en
prefLabel
Administration of apo A-I (Mil ...... F associated with hypertension
@en
P2093
P1433
P1476
Administration of apo A-I (Mil ...... F associated with hypertension
@en
P2093
Bart De Geest
Herman Kempen
Ilayaraja Muthuramu
P356
10.1038/S41598-020-65255-Y
P50
P577
2020-05-20T00:00:00Z